- Home
- Publications
- Publication Search
- Publication Details
Title
NAP Alpha-Aminoisobutyric Acid (IsoNAP)
Authors
Keywords
NAP (davunetide), NAP Alpha-Aminoisobutyric Acid (IsoNAP), β-sheet breaker, Neuroprotection, ADNP, ADNP-deficiency
Journal
JOURNAL OF MOLECULAR NEUROSCIENCE
Volume 52, Issue 1, Pages 1-9
Publisher
Springer Nature
Online
2013-09-09
DOI
10.1007/s12031-013-0103-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy
- (2013) S Quraishe et al. MOLECULAR PSYCHIATRY
- NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: Protection against impairments in axonal transport
- (2013) Yan Jouroukhin et al. NEUROBIOLOGY OF DISEASE
- Effects of Davunetide on N-acetylaspartate and Choline in Dorsolateral Prefrontal Cortex in Patients with Schizophrenia
- (2013) L Fredrik Jarskog et al. NEUROPSYCHOPHARMACOLOGY
- Protection Against Tauopathy by the Drug Candidates NAP (Davunetide) and D-SAL: Biochemical, Cellular and Behavioral Aspects
- (2012) Natalia Shiryaev et al. CURRENT PHARMACEUTICAL DESIGN
- D-NAP Prophylactic Treatment in the SOD Mutant Mouse Model of Amyotrophic Lateral Sclerosis: Review of Discovery and Treatment of Tauopathy
- (2012) Yan Jouroukhin et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- The ADNP Derived Peptide, NAP Modulates the Tubulin Pool: Implication for Neurotrophic and Neuroprotective Activities
- (2012) Saar Oz et al. PLoS One
- NAP (Davunetide) Provides Functional and Structural Neuroprotection
- (2011) Illana Gozes CURRENT PHARMACEUTICAL DESIGN
- Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia
- (2011) Daniel C. Javitt et al. SCHIZOPHRENIA RESEARCH
- Strategies for diminishing katanin-based loss of microtubules in tauopathic neurodegenerative diseases
- (2010) H. Sudo et al. HUMAN MOLECULAR GENETICS
- NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse—A microtubule-deficient model of schizophrenia
- (2010) Avia Merenlender-Wagner et al. PEPTIDES
- NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model
- (2009) Natalia Shiryaev et al. NEUROBIOLOGY OF DISEASE
- Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks
- (2008) Alexandra Bour et al. BEHAVIOURAL BRAIN RESEARCH
- A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease
- (2008) Y. Matsuoka et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Complete Sequence of a Novel Protein Containing a Femtomolar-Activity-Dependent Neuroprotective Peptide
- (2003) Merav Bassan et al. JOURNAL OF NEUROCHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started